OvaDx® Commercialization Strategy Top Priority SUNNYVALE, Calif. – Arrayit Corporation (OTCBB: ARYC), a leader in life sciences and healthcare technology, announces today that the company has hired an industry expert to identify strategic partnerships for the commercialization of OvaDx®, the company’s pre-symptomatic test for ovarian cancer. Arrayit Corporation and its subsidiary Arrayit Diagnostics, Inc. have […]
Combined company offers expanded line of products for multiplexing DNA, RNA and protein biomarker analysis and accelerates introduction of diagnostic products New Company to be Featured at AACC 2010 in Booth 6728 Press conference scheduled for Tuesday, July 27, 2010, at 10 a.m., in room 211B Poster presentation: E-29 Colorectal Cancer Gene Expression Profiling Using […]
AnyplexTM MDR-TB screening test identifies TB and genetic mutations leading to TB resistance to isoniazid and rifampicin ROCKVILLE, Maryland and SEOUL, Korea – The emergence and spread of drug-resistant mycobacterium tuberculosis (TB) threatens global TB control efforts, and there is an urgent need for new diagnostic tests that rapidly identify drug sensitivity profiles of TB […]
GE applying its revolutionary cancer mapping technology to identify early stage patients at higher risk for re-occurrence New molecular insights from GE’s mapping technology could promote better treatment selections for patients NISKAYUNA, NY – A team of scientists at GE Global Research, the technology development arm for the GE (NYSE: GE), has launched a study […]
Joint Publication on Differential Gene Expression from Small Number of Tumor Cells CAMBRIDGE, Mass. – Helicos BioSciences Corporation (NASDAQ: HLCS) today announced a publication entitled “Amplification-free digital gene expression profiling from minute cell quantities” appearing on line in Nature Methods co-authored by Dr. Daniel A. Haber and colleagues from Massachusetts General Hospital. The paper demonstrates […]
Multiplex real-time PCR test simultaneously screens for Gram (+), Gram (-), fungi and antibiotic resistant genes to deliver highly accurate results within three hours ROCKVILLE, Maryland and SEOUL, Korea — Seegene today announced the availability of Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. […]
SAN DIEGO – Illumina, Inc. (NASDAQ:ILMN) today announced the appointment of B. Melina Cimler, Ph.D., as Vice President, Quality and Regulatory Affairs, reporting to Christian Henry, Senior Vice President, Chief Financial Officer and General Manager, Life Sciences. Dr. Cimler will lead Illumina’s quality and regulatory organizations to support the development, manufacture and distribution of products […]
Hires M.D.s to Work Alongside Scientists in New $100 Million Research Initiative ARMONK, N.Y., – IBM (NYSE: IBM) today announced plans to enlist some of the company’s leading scientists and technologists to help medical practitioners and insurance companies provide high-quality, evidence-based care to patients. As part of this initiative, IBM is collaborating with clinicians in […]
DNA Fingerprinting Assays Run on Integrated ZyGEM/MicroLab Sample-to-Answer Platform Have Transformational Potential for Profiling Unknown Bacterial Samples Has Potential to Identify Up to 30 Different Bacterial Infectious Agents in Challenging Samples in Less than One Hour, a Dramatic Improvement over Current Methods Charlottesville, VA and Hamilton, New Zealand – ZyGEM Corp. Ltd., has introduced its […]
AUSTIN, Tex and CARLSBAD, Calif. – Asuragen, Inc. and Life Technologies Corporation (NASDAQ: LIFE) announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant™ Test, Asuragen’s clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
